Laura C Demmers
Overview
Explore the profile of Laura C Demmers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukherjee S, Sanchez-Bernabeu A, Demmers L, Wu W, Heck A
Front Immunol
. 2021 Dec;
12:796584.
PMID: 34925382
Mass-spectrometry based immunopeptidomics has provided unprecedented insights into antigen presentation, not only charting an enormous ligandome of self-antigens, but also cancer neoantigens and peptide antigens harbouring post-translational modifications. Here we...
2.
Hoek M, Demmers L, Wu W, Heck A
J Proteome Res
. 2021 Aug;
20(9):4518-4528.
PMID: 34415762
Presentation of antigens by human leukocyte antigen (HLA) complexes at the cell surface is a key process in the immune response. The α-chain, containing the peptide-binding groove, is one of...
3.
Demmers L, Wu W, Heck A
Mol Cell Proteomics
. 2021 May;
20:100089.
PMID: 33933681
Human leukocyte antigen (HLA) molecules play critical roles in our adaptive immune system by signaling a cell's health status to the immune system, through presentation of small peptides. Understanding HLA...
4.
Demmers L, Kretzschmar K, Van Hoeck A, Bar-Epraim Y, van den Toorn H, Koomen M, et al.
Nat Commun
. 2020 Oct;
11(1):5338.
PMID: 33087703
Tumor heterogeneity is a major cause of therapeutic resistance. Immunotherapy may exploit alternative vulnerabilities of drug-resistant cells, where tumor-specific human leukocyte antigen (HLA) peptide ligands are promising leads to invoke...
5.
Demmers L, Heck A, Wu W
J Proteome Res
. 2019 Feb;
18(4):1634-1643.
PMID: 30784271
HLA class Ι molecules can communicate a range of cellular alterations (mutations, changes in protein copy number, aberrant post-translational modifications, or pathogen proteins) to CD8+ T lymphocytes in the form...